Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beraprost sodium for acute cerebral infarction
ChiCTR2500109121Phase 4Not yet recruiting
- Sponsor
- Department of Neurology, Yongchuan Hospital, Chongqing Medical University
- Start
- Sep 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in brain infarction and ischemic stroke comparing Beraprost sodium with Placebo (2 arms). Primary endpoint: Neurological function score at day 90. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
beraprost
03
Conditions
brain infarctionischemic stroke
Beyond the preview
Go deeper on ChiCTR2500109121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500109121.